This comprehensive article covers everything about ovarian cancer, including risk factors, types, diagnosis, treatment options, and preventive strategies. Understanding these aspects can help women recognize early signs, seek timely medical attention, and explore effective treatment plans. Early detection and personalized care are vital for improving outcomes in ovarian cancer management. The article emphasizes the importance of genetic testing, lifestyle adjustments, and medical interventions to reduce risks and enhance quality of life.

• Age – Although ovarian cancer can develop at any age, the highest incidence is observed among women aged between 50 and 60 years. Menopause and hormonal changes during this period may influence cancer risk. Postmenopausal women may be more susceptible due to hormonal fluctuations that affect ovarian cell growth and regeneration. Nevertheless, younger women with genetic predispositions also face risk factors that require awareness and vigilance.

• Family history – Women with two or more close relatives who have experienced ovarian, breast, or other related cancers are at heightened risk. Genetic mutations inherited from parents play a vital role in this predisposition, emphasizing the importance of family health history in assessing risk levels.

• Hormone replacement therapy – Long-term use of high-dose estrogen supplements, especially in postmenopausal women, can elevate ovarian cancer risk. The hormonal environment influences cellular proliferation in the ovaries, making it essential for hormone therapy to be monitored closely by healthcare providers.

• Early or late onset of menstruation – Women who begin menstruating at a very early age or reach menopause late are at increased risk due to prolonged exposure to hormonal cycles, which may promote abnormal cell growth in ovarian tissues.

• Inherited gene mutations – Certain genetic alterations significantly increase ovarian cancer risk. Notably, mutations in the BRCA1 and BRCA2 genes are strongly linked to higher incidences. Women with Lynch syndrome, a hereditary condition, also face elevated risks. Genetic testing and counseling can help identify women at risk, facilitating early screening and preventive measures.

Origin and histology determine the type of ovarian cancer, which influences prognosis and treatment approaches. The main categories include:

• Epithelial tumors – This is the most common form, accounting for about 90% of ovarian cancers. It develops in the thin, flat tissue covering the ovary's surface, also known as the epithelium. Epithelial tumors can be further subdivided into serous, mucinous, endometrioid, and clear cell types, each with distinct pathological features.
• Stromal tumors – Arising from the connective tissue that produces hormones like estrogen and progesterone, these tumors are relatively rare, representing approximately 7% of cases. They tend to be diagnosed earlier than epithelial cancers and may produce hormonal symptoms such as abnormal bleeding or hormonal imbalance.
• Germ-cell tumors – Developing in the reproductive cells that generate eggs, germ-cell tumors are uncommon and usually affect younger women. They can be malignant or benign and may present as rapid-growing masses requiring prompt diagnosis.

Early diagnosis is complicated because symptoms often mimic benign gynecological issues. Healthcare professionals employ several diagnostic tools:

• Routine examinations allow physicians to palpate ovarian and abdominal structures for abnormal growths or irregularities.
• Imaging studies – Ultrasound, both transvaginal and abdominal, provides detailed images of ovarian structures. Computed tomography (CT) scans help assess tumor size, spread, and involvement of surrounding tissues.
• Blood tests – Measuring levels of CA-125, a tumor marker, assists in screening and monitoring treatment response. However, elevated CA-125 alone cannot confirm diagnosis, as it may be increased in benign conditions as well.
• Biopsy and surgical intervention – When non-invasive tests suggest malignancy, surgical removal of the suspected mass allows definitive diagnosis through histopathological examination. Laparoscopy or laparotomy may be performed depending on tumor size and location.

Management of ovarian cancer involves a multidisciplinary approach tailored to the stage and type of the disease:

• Surgical procedures – Surgeries range from removing one ovary to comprehensive procedures removing both ovaries, fallopian tubes, uterus, and affected surrounding tissues. The extent depends on tumor spread and patient health. Surgical debulking aims to eliminate as much cancer as possible to enhance subsequent treatments.
• Chemotherapy – Using potent drugs to kill residual cancer cells post-surgery or as a primary treatment in advanced cases. Common chemotherapy regimens include platinum-based compounds like carboplatin and taxanes such as paclitaxel. The mode of administration varies—intravenous, intraperitoneal, or oral—based on individual cases.
• Targeted therapy – This innovative treatment targets specific vulnerabilities or molecular pathways in cancer cells. Drugs like PARP inhibitors are effective in patients with BRCA mutations. Targeted therapies are often utilized in recurrent or resistant cases to improve outcomes.
• Palliative care – Focused on symptom relief and quality of life, palliative treatments help manage pain, fatigue, and other distressing symptoms. This holistic approach involves pain management, psychological support, and coordination with family and care teams.

While there is no guaranteed way to prevent ovarian cancer, risk-reducing actions can lower likelihood:

• Use of birth control pills – Long-term use of oral contraceptives has been linked to a decreased risk, possibly due to suppression of ovulation.
• Pregnancy and breastfeeding – These reproductive factors are associated with a reduced risk, likely due to fewer ovulation cycles.
• Surgical interventions – Procedures like tubal ligation or hysterectomy can lower risk but come with their own considerations. It’s imperative to discuss with a healthcare provider to understand benefits and risks fully.
• Genetic counseling and testing – For women with a family history, genetic screening can inform personalized preventive strategies and early detection plans.

Ovarian cancer remains a significant health challenge due to its subtle early signs and complex risk factors. Awareness, regular screenings, and genetic testing are key to early detection, which can significantly improve treatment outcomes. Advances in targeted therapies continue to offer hope for better management and survival rates. Women should consult healthcare professionals for personalized assessments and adopt proactive health measures to mitigate their risk.